Rein Therapeutics, Inc.
Pharmaceutical company · Austin, Texas, United States · Nasdaq: RNTX
Rein Therapeutics, Inc. is a pharmaceutical company headquartered in Austin, Texas, United States. Its shares trade on Nasdaq under the ticker RNTX. It has reported private securities offerings to the US SEC, most recently $18 million sold in a notice filed in 2023.
Rein Therapeutics at a glance
What does Rein Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $18.3 million sold (2023).
Frequently asked questions about Rein Therapeutics
Where is Rein Therapeutics headquartered?
Rein Therapeutics, Inc. is headquartered in Austin, Texas, United States.
What does Rein Therapeutics do?
Rein Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Rein Therapeutics a public company?
Yes. Rein Therapeutics, Inc. trades on Nasdaq under the ticker RNTX.
Similar companies
- Savara IncAustin, Texas, United States
- Lumos Pharma, Inc.Austin, Texas, United States
- Lung Therapeutics, Inc.Austin, Texas, United States
- TFF Pharmaceuticals, Inc.Austin, Texas, United States
- Shattuck Labs, Inc.Austin, Texas, United States
- Faeth Therapeutics, Inc.Austin, Texas, United States
- Genprex, Inc.Austin, Texas, United States
- Filana Therapeutics, Inc.Austin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.